KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Current Assets (2016 - 2025)

Historic Current Assets for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $376.3 million.

  • Neogenomics' Current Assets fell 3686.68% to $376.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $376.3 million, marking a year-over-year decrease of 3686.68%. This contributed to the annual value of $376.3 million for FY2025, which is 3686.68% down from last year.
  • Per Neogenomics' latest filing, its Current Assets stood at $376.3 million for Q4 2025, which was down 3686.68% from $382.5 million recorded in Q3 2025.
  • Neogenomics' Current Assets' 5-year high stood at $942.7 million during Q1 2021, with a 5-year trough of $376.3 million in Q4 2025.
  • Over the past 5 years, Neogenomics' median Current Assets value was $593.1 million (recorded in 2024), while the average stood at $598.1 million.
  • Its Current Assets has fluctuated over the past 5 years, first surged by 33758.04% in 2021, then tumbled by 3686.68% in 2025.
  • Neogenomics' Current Assets (Quarter) stood at $681.5 million in 2021, then decreased by 11.18% to $605.3 million in 2022, then dropped by 1.4% to $596.8 million in 2023, then dropped by 0.13% to $596.0 million in 2024, then plummeted by 36.87% to $376.3 million in 2025.
  • Its Current Assets was $376.3 million in Q4 2025, compared to $382.5 million in Q3 2025 and $392.6 million in Q2 2025.